Clinical Trials Browser

Phase 2 × Vaccinia × Clear all

NCT07006077 2026-02-27

Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer

Phase 2 Recruiting

Gastrointestinal

Pancreatic Neoplasms, Vaccinia

NCT06463665 2025-09-26

VIRO-25

Phase 2 Recruiting

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Vaccinia

NCT01171651 2016-01-20

A Study of Recombinant Vaccinia Virus Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Vaccinia

NCT01387555 2015-03-11

TRAVERSE

Phase 2 Completed

Gastrointestinal

Oculocerebral hypopigmentation syndrome type Preus, Carcinoma, Hepatocellular, Liver Neoplasms, Vaccinia

NCT02017678 2014-09-17

Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin

Phase 2 Withdrawn

Carcinoma, Ovarian Neoplasms, Vaccinia